To this point, we verified the absence of toxicity, specifically the absence of colitis, by demonstrating that ST2+ Treg cells are present in the healthy gut and no changes in mouse body weight, colon length, and long-term Treg cell frequencies occurred with anti-ST2 antibody treatment. The gene discussed is IL1RL1; the disease is colitis.